Topics

Experts Statements: Ingrid Hegbom Ekman, Cambrex

Experts Statements: Kurt J. Kiewel, Cambrex

Experts Statements: Dr. Karl Kolter, BASF

Experts Statements: Dr. Ralph O. Schoenleber, Bachem

Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs. Indeed, medicinal chemists face a challenge of their own. Trying to survive in a changing environment where pharma is focusing on biologics drug candidates will require chemists to adapt.

Experts Statements: Dr. Jürgen Sans, Alzchem

Experts Statements: Lukas von Hippel, Pharma Waldhof

Experts Statements: Dr. Michael Quirmbach, Corden-Pharma International

Experts Statements: Stef L.E. Heylen, Janssen R&D

Experts Statements: Prof. Jochen Maas, Sanofi-Aventis Deutschland

Experts Statements: Dr. Timo Flessner, Bayer

The Winning Formula

Experts Statements: Dr. Alexander Biedermann, AstraZeneca Germany

The Ecosystem of Chemical Parks

Millireactor in Production

Improving Resilience to Supply Chain Disruption

Challenges Evolve In China

Top Business Climate Meets Excellent Talent Pool

South America’s Chemical Industry in Recession

Chemistry Works – at Every Level

Brexit’s Implications for the UK’s Chemical Industry

Innovation Makes A Difference

Global Competitiveness Index

EPCA Celebrates its 50th Anniversary Annual Meeting in Budapest

'Always Solving' - Ashland Launches New Brand

At the Crossroads of Technology and Information

Pharmaceutical Logistics: Temperature-controlled Exports and European Distribution

Cerbios' new State-of the-art R&D Centre for HPAI and mAb Development

Cambrex Announces Investment & Expansion

Free Tipsheet: 3 Reasons to Consider Text Mining

Diagnosis: Innovation Insufficiency – Treatment: Combination Therapy

Pharmaceutical Logistics as a Brand

Serialization – the Bigger Picture

ISPE Recognizes Leaders in Drug Shortage Prevention

Opportunities in Drug Development and Manufacturing

Growth in the global oncology drug market is an important measure of opportunities in drug development and manufacturing, including for contract manufacturers of active pharmaceutical ingredients (APIs) and finished drug products.

A New Pathway